CIK 0001355790
- Non-accelerated filer
- Smaller reporting company
International Stem Cell CORP
Sign in to watch- Ticker
- ISCO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204494098
- Phone
- +1 760-940-6383
- Business address
- 9745 BUSINESSPARK AVENUE, SAN DIEGO, CA, 92131
- Former names
- BTHC III INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,497
- in 1 filing
Net −$10,497. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-17 | Semechkin Andrey Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2016-05-17 | MAIER PAUL V Director | Grant or award · Stock Option (Right to Buy) | −30,000 | 30,000 | ||
| 2016-05-17 | Ebrahimi Mahnaz Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2016-05-17 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (Right to Buy) | −30,000 | 30,000 | ||
| 2016-03-31 | Don Wright Director | Grant or award | +2,104 | 12,707 | ||
| 2016-03-31 | MAIER PAUL V Director | Grant or award | +2,104 | 11,128 | ||
| 2016-03-31 | CASAMENTO CHARLES J Director | Grant or award | +2,104 | 12,207 | ||
| 2016-03-24 | Kern Russell EVP, Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | −180,000 | 180,000 | ||
| 2016-03-24 | Ebrahimi Mahnaz Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | −20,000 | 20,000 | ||
| 2016-03-24 | Bakalova Sofya VP Legal Affairs & Operations | Grant or award · Stock Option (Right to Buy) | −120,000 | 120,000 | ||
| 2016-03-15 | Semechkin Andrey Chief Executive Officer | Purchase · Series I-2 Preferred Stock | −4,310 | $1,000.00 | $4.3M | 4,310 |
| 2016-03-15 | Semechkin Andrey Chief Executive Officer | Purchase · Series A Warrant (Right to Buy) | −2,462,856 | 2,462,856 | ||
| 2016-03-15 | Semechkin Andrey Chief Executive Officer | Purchase · Series B Warrant (Right to Buy) | −2,462,856 | 2,462,856 | ||
| 2016-03-15 | Semechkin Andrey Chief Executive Officer | Purchase · Series C Warrant (Right to Buy) | −2,462,856 | 2,462,856 | ||
| 2015-12-31 | Don Wright Director | Grant or award | +2,403 | 10,603 | ||
| 2015-12-31 | MAIER PAUL V Director | Grant or award | +2,403 | 9,024 | ||
| 2015-12-31 | CASAMENTO CHARLES J Director | Grant or award | +2,403 | 10,103 | ||
| 2015-11-24 | Semechkin Andrey Chief Executive Officer | Option exercise | +39,294 | $1.79 | $70K | 652,151 |
| 2015-11-24 | Semechkin Andrey Chief Executive Officer | Option exercise · Series A Warrant (Right to Buy) | −39,294 | 0 | ||
| 2015-11-23 | Semechkin Andrey Chief Executive Officer | Conversion | +211,900 | $1.79 | $380K | 612,857 |
Page 10 of 15 · 298 trades